---
figid: PMC5420131__13045_2017_471_Fig1_HTML
figtitle: 'Canonical Wnt/Beta-catenin pathway: “WNT ON state”: WNT proteins, by binding
  to frizzled receptors and the LRP co-receptor, act to suppress the activity of glycogen
  synthase kinase-3B (GSK-3B)'
organisms:
- Gallus gallus
- Xenopus laevis
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Lareunionomyces loeiensis
- Mouse mammary tumor virus
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
- Mus musculus
- Gallus gallus
- Xenopus laevis
pmcid: PMC5420131
filename: 13045_2017_471_Fig1_HTML.jpg
figlink: /pmc/articles/PMC5420131/figure/Fig1/
number: F1
caption: 'Canonical Wnt/β-catenin pathway: “WNT ON state”: WNT proteins, by binding
  to frizzled receptors and the LRP co-receptor, act to suppress the activity of glycogen
  synthase kinase-3β (GSK-3β). ZNRF3 promotes degradation of WNT receptor functioning
  as tumor suppressors. This prevents phosphorylation of downstream molecules allowing
  β-catenin association with Tcf/Lef in the nucleus and subsequent increased cell
  proliferation. “WNT OFF state”: In the absence of WNT ligand, the destruction complex
  of β-catenin (marked by dotted line box), a tertiary complex formed by axin, APC,
  CK1α and GSK 3β, will phosphorylate β-catenin, which subsequently undergoes proteasomal
  degradation'
papertitle: 'Wnt/beta-catenin pathway: modulating anticancer immune response.'
reftext: Sachin Gopalkrishna Pai, et al. J Hematol Oncol. 2017;10:101.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9805424
figid_alias: PMC5420131__F1
figtype: Figure
redirect_from: /figures/PMC5420131__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5420131__13045_2017_471_Fig1_HTML.html
  '@type': Dataset
  description: 'Canonical Wnt/β-catenin pathway: “WNT ON state”: WNT proteins, by
    binding to frizzled receptors and the LRP co-receptor, act to suppress the activity
    of glycogen synthase kinase-3β (GSK-3β). ZNRF3 promotes degradation of WNT receptor
    functioning as tumor suppressors. This prevents phosphorylation of downstream
    molecules allowing β-catenin association with Tcf/Lef in the nucleus and subsequent
    increased cell proliferation. “WNT OFF state”: In the absence of WNT ligand, the
    destruction complex of β-catenin (marked by dotted line box), a tertiary complex
    formed by axin, APC, CK1α and GSK 3β, will phosphorylate β-catenin, which subsequently
    undergoes proteasomal degradation'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ZNRF3
  - AXIN1
  - AXIN2
  - GSK3B
  - CTNNB1
  - TEF
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - 'On'
  - 'Off'
  - fz
  - Liprin-alpha
  - Axn
  - sgg
  - gskt
  - arm
  - tef
  - tefu
  - pan
  - Fas
  - Znrf3
  - Axin1
  - Gsk3b
  - Ctnnb1
  - Tef
  - LEPR
  - GSK3A
  - znrf3.S
  - axin1.S
  - gsk3b.L
  - gsk3b.S
  - ctnnb1.S
  - ctnnb1.L
  - dbp.L
  - tef.S
---
